Ignite Creation Date:
2025-12-24 @ 7:21 PM
Ignite Modification Date:
2025-12-27 @ 7:23 PM
Study NCT ID:
NCT05689203
Status:
UNKNOWN
Last Update Posted:
2023-01-19
First Post:
2023-01-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 2 Study to Evaluate the Efficacy and Safety of QLS1128 Orally in Symptomatic Participants With Mild to Moderate COVID-19
Sponsor:
Qilu Pharmaceutical Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-12-30
Start Date Type:
ACTUAL
Primary Completion Date:
2023-02-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-02-01
Completion Date Type:
ESTIMATED
First Submit Date:
2023-01-15
First Submit QC Date:
None
Study First Post Date:
2023-01-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-01-15
Last Update Post Date:
2023-01-19
Last Update Post Date Type:
ACTUAL